{"prompt": "['2017N330177_04', 'CONFIDENTIAL', '205678', 'Section # and Name', 'Description of Change', 'Brief Rationale', 'Section 7.2.2 Dose', 'Permitted dose reductions have', 'Dose reductions updated per', 'Reductions for Toxicity', 'been included. Table 10 updated.', 'design change to 2 dose levels.', 'Table 10', 'Section 7.2.2 Dose', 'Modified grading of corneal events', 'As the AE grading scale is now', 'Reductions for Toxicity', 'by deleting the presence of', 'based on corneal clinical', 'Table 13', 'asymptomatic corneal findings on', 'symptoms and visual acuity, this', 'ophthalmic exam not observed at', 'situation (asymptomatic findings)', 'baseline (grade 1)', 'is no longer applicable as all', 'findings will be considered AEs.', 'Changes made due to regulatory', 'agency recommendations.', 'Editorial changes to clarify that', 'artificial tears are to be increased', 'for other AE grades.', 'Modified management of corneal', 'events, i.e. dosage of preservative', 'free artificial tears has been', 'Editorial changes to reflect prior', 'increased for G4 corneal events.', 'allogenic transplants are now', \"Footnote 'C' regarding patients with\", 'excluded, thus footnote is', 'prior allogenic transplant with', 'unnecessary.', 'corneal toxicity has been deleted:', 'Section 7.3 Method of', 'Section 7.3 updated for', '7.3 changes address', 'Treatment Assignment', 'randomization and stratification', 'randomizing to 2 arms.', 'information for treatment', 'assignment.', 'Section 8.1', 'Deletion of language that allowed', 'Decision made to treat all', 'Discontinuation of', 'participants who have achieved CR', 'patients until PD', 'Study Treatment', 'to discontinue treatment.', 'Section 8.2.5 Corneal', 'Management guidelines for corneal', 'Guidelines updated according to', 'Supportive Care', 'events updated.', 'feedback from regulatory agency.', 'Guidelines', 'Section 8.2.6', 'Language added to reference Table', 'Added to reinforce the actions', '11', 'based on a Grade 4 IRR.', '148']['2017N330177_04', 'CONFIDENTIAL', '205678', 'Section # and Name', 'Description of Change', 'Brief Rationale', 'Section 9 Study', 'Baseline demographic assessment', 'Editorial updates: demographics', 'Assessments and', 'and medical family history', 'and medical history were added.', 'Procedures', 'assessment included', 'Section 9.2 Adverse', 'General language corrections made', 'Events', 'for clarity.', 'Adverse event coding by MedDRA', 'and grading by NCI-CTCAE included', 'Section 9.1 Efficacy', 'IgG, IgM and IgA assessments and', 'To provide additional clarification', 'Assessment', 'additional bone marrow testing', 'included', 'Section 9.2.10 Ocular', 'The language in the Ocular Sub-', 'Language modified to clarify the', 'Sub-Study', 'Study Examinations section has', 'required examinations and', 'Examination', 'been updated for increased clarity', 'palliative treatment for', 'The language in Ocular Sub-study', 'participants in this cohort.', 'Recommendations from', 'examinations now modified to', 'remove confrontation of visual fields,', 'independent corneal experts.', 'evaluation of optic nerve and retina.', 'Tear film examination, anterior', 'segment photography, and', 'pachymetry were added. Fundus', 'and anterior segment photography', 'are now included at baseline, end of', 'study, and last follow-up visit.', '9.2.10.1 Monocular', 'Registration into RAMOS after', 'The section for monocular', 'Prophylaxis', 'assessment completion deleted.', 'prophylaxis has been updated to', 'Additional information and schematic', '9.2.10.2 Monocular', 'clarify the treatment.', 'Treatment', 'for prophylactic eye drops included.', '9.2.10.3 Sub-Study', 'Exams', '9.2.9 (old)', 'The section on assessment of', 'Removed as this information is', 'sentinel events deleted.', 'specific to a GSK process rather', 'than something the sites must', 'do. This will be captured in the', 'SRM.', '149']\n\n###\n\n", "completion": "END"}